Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.

Li HL, Liang S, Cui JH, Han GY

Open source

DOI
10.26355/eurrev_201801_14109
Published
2018 Jan
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201801_14109,
  title = {Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.},
  author = {Li HL and Liang S and Cui JH and Han GY},
  year = {2018},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201801_14109},
  url = {https://doi.org/10.26355/eurrev_201801_14109}
}

RIS

TY  - JOUR
TI  - Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
AU  - Li HL
AU  - Liang S
AU  - Cui JH
AU  - Han GY
PY  - 2018
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201801_14109
UR  - https://doi.org/10.26355/eurrev_201801_14109
ER  - 

APA

HL, L., S, L., JH, C., & GY, H. (2018). Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201801_14109

Source records